×
About 550 results

ALLMedicine™ Activated Clotting Time Center

Research & Reviews  206 results

A Comparison of Anticoagulation Strategies in Veno-venous Extracorporeal Membrane Oxyge...
https://doi.org/10.1097/MAT.0000000000001560
ASAIO Journal (American Society for Artificial Internal O... Shah A, Pasrija C et. al.

Aug 27th, 2021 - Bleeding remains a major source of morbidity associated with veno-venous extracorporeal membrane oxygenation (VV-ECMO). Moreover, there remains significant controversy, and a paucity of data regarding the ideal anticoagulation strategy for VV-ECMO...

Heparin Monitoring with an Anti-Xa Protocol Compared to Activated Clotting Time in Pati...
https://doi.org/10.1177/10600280211039582
The Annals of Pharmacotherapy; Feih JT, Wallskog KE et. al.

Aug 24th, 2021 - Temporary mechanical circulatory support (tMCS) devices are used for patients with severe cardiac or respiratory failure; however, these patients are at high risk for clotting and bleeding. The best method to monitor heparin in these patients has ...

Differences in activated clotting time and total unfractionated heparin dose during pul...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364723
Clinical Cardiology; Zeljkovic I, Brusich S et. al.

Jul 2nd, 2021 - Periprocedural pulmonary vein isolation (PVI) anticoagulation requires balancing between bleeding and thromboembolic risk. Intraprocedural anticoagulation is monitored by activated clotting time (ACT) with target value >300 s, and there are no gui...

The Standard Point-of-Care Hemochron Jr. ACT+ Test in Monitoring Heparin Administration...
https://doi.org/10.1053/j.jvca.2021.05.021
Journal of Cardiothoracic and Vascular Anesthesia; Erkinaro T, Moilanen J et. al.

Jun 17th, 2021 - Coagulation factor XII (FXII) is a plasma serine protease that belongs to the contact activation complex responsible for initiating the intrinsic coagulation pathway. FXII deficiency is a rare congenital disorder that is not associated with an inc...

Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorpore...
https://doi.org/10.1177/08971900211021249
Journal of Pharmacy Practice; Northam KA, Nguyen B et. al.

Jun 11th, 2021 - Anticoagulation monitoring practices vary during extracorporeal membrane oxygenation (ECMO). The Extracorporeal Life Support Organization describes that a multimodal approach is needed to overcome assay limitations and minimize complications. Comp...

see more →

Drugs  2 results see all →

News  12 results

Heparin Dosing Oddities in the Cath Lab: A 'Red Flag' Raises Questions
https://www.medscape.com/viewarticle/918035

Sep 10th, 2019 - The peculiar heparin behavior started about 6 months ago. Dosing that had been reliable countless times in the cath lab was failing to get the activated clotting time (ACT) to target, forcing extra boluses. "I called my pharmacy and asked them to ...

Heparin Dosing Oddities in the Cath Lab: A 'Red Flag' Raises Questions
https://www.staging.medscape.com/viewarticle/918035

Sep 10th, 2019 - The peculiar heparin behavior started about 6 months ago. Dosing that had been reliable countless times in the cath lab was failing to get the activated clotting time (ACT) to target, forcing extra boluses. "I called my pharmacy and asked them to ...

BRAVO 3: Bivalirudin No Better Than Heparin in TAVR
https://www.staging.medscape.com/viewarticle/852748

Oct 15th, 2015 - SAN FRANCISCO, CA — For patients undergoing transcatheter aortic-valve replacement (TAVR) via the femoral artery, the use of bivalirudin (Angiomax, the Medicines Company) did not significantly reduce the risk of bleeding, nor did it use reduce the...

Dosing the New Oral Anticoagulants in Atrial Fib: Can We Do Better?
https://www.medscape.com/viewarticle/829331

Aug 4th, 2014 - NEW YORK, NY — "Oral administration, please, but no cumbersome dosing strategies" could have been the tag line of the research community that spent decades looking for a more user-friendly alternative that is at least comparable to warfarin in eff...

Cardio Notes: Catheter Fix Cuts Leg Loss.
https://www.medpagetoday.com/cardiology/peripheralarterydisease/39580

Jun 3rd, 2013 - As surgeons use more minimally-invasive approaches to treat peripheral arterial disease, fewer patients need amputations. Also, testing dabigatran's therapeutic level, and the future cost of treating aortic stenosis. Lower Limb Amputations Down Ov...

see more →